Development on Tumor Associated Antigen with Specific Target toward Lung Cancer: Recent Developments | Chapter 19 | Innovations in Medicine and Medical Research Vol. 2
Tumor
liberated protein (TLP) has been previously described as a TAA (complex)
present in the sera from lung cancer patients with early stage disease. Since
early detection improves overall survival in lung cancer, identification of
screening biomarkers for patients at risk for the development of this disease
represents an important target. Starting from the peptide epitope RTNKEASI
previously isolated from TLP complexes, we generated a rabbit anti-RTNKEASI
serum. This antiserum detected and immunoprecipitated a 55 kDa protein band in
the lysate of the lung cancer cell line A549. This protein band was identified
as aldehyde dehydrogenase is form 1A1 through mass spectrometry, revealing the
molecular nature of at least one component of the previously described TLP
complex.
Author(s) Details
Giulio Tarro
Beaumont Bonelli Foundation for Cancer Research, Naples, Italy and Committee on Biotechnologies and VirusSphere, World Academy of Biomedical Technologies, UNESCO, Paris, France.
View Book : - http://bp.bookpi.org/index.php/bpi/catalog/book/161
Author(s) Details
Giulio Tarro
Beaumont Bonelli Foundation for Cancer Research, Naples, Italy and Committee on Biotechnologies and VirusSphere, World Academy of Biomedical Technologies, UNESCO, Paris, France.
View Book : - http://bp.bookpi.org/index.php/bpi/catalog/book/161
Comments
Post a Comment